Want to join the conversation?
Clinical diagnostic kits maker $VIVO said it has received clearance from FDA for new illumigene Pertussis molecular amplification test claims, which reduces the effect of inhibitors in biologic samples. This test expands Company's customer base by including specimens collected by ESwab, a liquid-based collection and transport system.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!